These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 892912)

  • 21. Acid precipitation of Clostridium botulinum type C and D toxins from whole culture by addition of ribonucleic acid as a precipitation aid.
    Iwasaki M; Sakaguchi G
    Infect Immun; 1978 Feb; 19(2):749-51. PubMed ID: 344224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
    Matsuda M; Ozutsumi K; Du PY; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular construction of Clostridium botulinum type F progenitor toxin.
    Ohishi I; Sakaguchi G
    Appl Microbiol; 1975 Apr; 29(4):444-7. PubMed ID: 235882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.
    Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1977 Aug; 30(4):179-90. PubMed ID: 20527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of nontoxic-nonhemagglutinin component of the two types of progenitor toxin (M and L) produced by Clostridium botulinum type D CB-16.
    Ohyama T; Watanabe T; Fujinaga Y; Inoue K; Sunagawa H; Fujii N; Inoue K; Oguma K
    Microbiol Immunol; 1995; 39(7):457-65. PubMed ID: 8569530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simplified purification method for Clostridium botulinum type E toxin.
    Giménez JA; Sugiyama H
    Appl Environ Microbiol; 1987 Dec; 53(12):2827-30. PubMed ID: 3435146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nature of intracellular type A botulinum neurotoxin.
    Krysinski EP; Sugiyama H
    Appl Environ Microbiol; 1981 Mar; 41(3):675-8. PubMed ID: 7013709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium botulinum type E toxins bind to Caco-2 cells by a different mechanism from that of type A toxins.
    Zhang K; Yamamoto Y; Suzuki T; Yokota K; Ma S; Ni Nengah Dwi Fatmawati ; Oguma K
    Acta Med Okayama; 2012; 66(3):253-61. PubMed ID: 22729106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of nicking of the nontoxic-nonhemagglutinin components of Clostridium botulinum types C and D progenitor toxin.
    Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    J Protein Chem; 2000 Oct; 19(7):575-81. PubMed ID: 11233171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813.
    Watanabe T; Sagane Y; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    J Protein Chem; 1999 Oct; 18(7):753-60. PubMed ID: 10691185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular composition of Clostridium botulinum type A progenitor toxins.
    Inoue K; Fujinaga Y; Watanabe T; Ohyama T; Takeshi K; Moriishi K; Nakajima H; Inoue K; Oguma K
    Infect Immun; 1996 May; 64(5):1589-94. PubMed ID: 8613365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex.
    Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Obata S; Oguma K; Ohyama T
    Biochem Biophys Res Commun; 2002 Mar; 292(2):434-40. PubMed ID: 11906181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873.
    Nakajima H; Inoue K; Ikeda T; Fujinaga Y; Sunagawa H; Takeshi K; Ohyama T; Watanabe T; Inoue K; Oguma K
    Microbiol Immunol; 1998; 42(9):599-605. PubMed ID: 9802560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947.
    Hasegawa K; Watanabe T; Sato H; Sagane Y; Mutoh S; Suzuki T; Yamano A; Kouguchi H; Takeshi K; Kamaguchi A; Fujinaga Y; Oguma K; Ohyama T
    Protein J; 2004 Aug; 23(6):371-8. PubMed ID: 15517984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia.
    Arimitsu H; Inoue K; Sakaguchi Y; Lee J; Fujinaga Y; Watanabe T; Ohyama T; Hirst R; Oguma K
    Infect Immun; 2003 Mar; 71(3):1599-603. PubMed ID: 12595486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular diversity of neurotoxins from Clostridium botulinum type D strains.
    Moriishi K; Syuto B; Kubo S; Oguma K
    Infect Immun; 1989 Sep; 57(9):2886-91. PubMed ID: 2668193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of Clostridium botulinum type B toxin by an endogenous enzyme.
    DasGupta BR
    J Bacteriol; 1971 Dec; 108(3):1051-7. PubMed ID: 4945183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difficulties of molecular dissociation of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):165-70. PubMed ID: 1905655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of a protease in natural activation of Clostridium botulinum neurotoxin.
    Das Gupta BR; Sugiyama H
    Infect Immun; 1972 Oct; 6(4):587-90. PubMed ID: 4564288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.